This episode is brought to you by Slack. With Slack, you can bring all your people and

tools together in one place. It's your digital HQ where you can increase productivity,

enable flexibility and automate workflows. Plus, Slack is full of game-changing features

like huddles for quick check-ins or Slack Connect, which helps you connect with partners

inside and outside of your company. Slack, where the future works. Get started at

Slack.com slash DHQ.

From Cafe, welcome to Stay Tune.

I'm Pete Barara. Anything that comes into court wearing the mantle, the robe of science,

claiming all of the trappings of science ought to have to live up to the standards of science.

That's Eric Lander. He's the president and co-founder of MIT and Harvard's Broad Institute.

It's a biomedical research lab that has played a central role in the development of CRISPR,

a gene editing technology with profound implications for the future of disease and human development.

A seminal figure in the mapping of the human genome. Lander has been a laboratory researcher,

Harvard and MIT professor, and a thought leader in the growing field of genetics for more

than three decades. Lately, he's been focusing on creating global rules for gene editing,

helping to jump start innovative research companies and finding more reliable ways to use

DNA forensics as evidence in criminal trials. We'll get into all of that, plus the history

of the human genome project, the risks and rewards of scientific progress, and the role of

the United States and the global quest to eradicate disease. That's coming up. Stay tuned.

Hey folks, now it's time to get to your questions. I'm traveling with my family in Israel this week,

so I didn't expect to be fully plugged into minute by minute news, so I took this opportunity

to answer some questions that are not based on the ever-changing news cycle. Next week,

...